Sponsor or institution

Clinical trials and research at Entrada Therapeutics, Inc.

• 2Clinical trials
• 5Countries

All recruiting trials (2)

• ENTR-601-45 for Duchenne muscular dystrophy patients amenable to exon 45 skipping

  This trial will test whether ENTR-601-45 given by intravenous infusions is safe and helps boys and young men with Duchenne muscular dystrophy who are amenable to exon 45 skipping.

  Recruiting at 14 sites Phase 1/2 Entrada Therapeutics, Inc. · Ghent and 14 other locations · NCT07038824

• ENTR-601-44 treatment for Duchenne muscular dystrophy eligible for exon 44 skipping

  This trial will test whether intravenous ENTR-601-44 is safe and helps boys and young men with Duchenne muscular dystrophy whose genetics make them eligible for exon 44 skipping, compared with a placebo.

  Recruiting at 13 sites Phase 1/2 Entrada Therapeutics, Inc. · Ghent and 13 other locations · NCT07037862

Quick answers

How many clinical trials run by Entrada Therapeutics, Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in Belgium (2 trials), Italy (2 trials), Spain (2 trials), United Kingdom (2 trials), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →